Regulations.gov document
Microbiology Devices; Reclassification of Cytomegalovirus Deoxyribonucleic Acid…
Rule · FDA-2016-N-2880 · posted Sep 23, 2024
Key facts
| Document ID | FDA-2016-N-2880-0007 |
|---|---|
| Title | Microbiology Devices; Reclassification of Cytomegalovirus Deoxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2016-N-2880 |
| Posted | Sep 23, 2024 |
| Federal Register citation | 89 FR 77448 |
| FR document number | 2024-21616 |
| CFR | 21 CFR Part 866 |
| Comment period opens | Sep 23, 2024 |
| Effective date | Sep 23, 2024 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: